Part 2a of a six part series covering the fundamentals of magnetic resonance imaging physics. In this section, Dr. Stafford introduces concepts of relaxation and image contrast. Click here to view Part 1a or Part 2b.
Terms covered in Part 2:
Part 1b of a six part series covering the fundamentals of magnetic resonance imaging physics. In this primer, Dr. Stafford discusses the course outline and basic physics of precession and excitation. Click here to view Part 1a.
Terms covered in Part 1:
Part 1a of a six part series covering the fundamentals of magnetic resonance imaging physics. In this primer, Dr. Stafford discusses the course outline and basic physics of precession and excitation. Click here for Part 1b.
Terms covered in Part 1:
Please join us on June 19th and 20th 2014, at the beautiful Ottawa Convention Centre, for the 7th Annual Molecular Function and Imaging (MFI) Symposium. The MFI Symposium will bring together multidisciplinary fields to discuss exciting new advances in the development and application of imaging for the study, detection and treatment of cardiovascular disease. The event offers the perfect platform for young scientists to interact with leading experts in the field and network with future mentors and collaborators.
Complementary Registration Fee for all trainees submitting an abstract. Submit your abstract TODAY! Abstract submission closed 23 May 2014. For more information see: http://www.ottawaheart.ca/research_discovery/mfi-symposium_about-mfis.htm
Trainees, Research Staff, and New Investigators from outside the Ottawa area who are working on CAIN or MITNEC-related projects who wish to receive partial support to attend this meeting (flight and two-days of accommodation) are invited to concurrently 1) send their abstracts to This email address is being protected from spambots. You need JavaScript enabled to view it. prior to the 23 May 2014 deadline; 2) register as a user on imagingkt.ca; and 3) provide an introduction on the Welcome Mat board in the Forum section of imagingkt.ca
Headquartered at the University of Calgary
Rm 1105, South Tower
1403 29 Ave NW
Calgary, AB T2N 2T9
This email address is being protected from spambots. You need JavaScript enabled to view it.
Project Lead: Dr. Richard Frayne
rfrayne {at} ucalgary.ca
Web Administrator: Mark Winder
mwinder {at} ucalgary.ca
The Tri-Council is a unified body of the three federal granting agencies; Canadian Institutes for Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Social Sciences and Humanities Research Council of Canada (SSHRC). Together, they offer an impressive funding opportunity to graduate students before or within their first year of graduate education. If you are interested in graduate science or medical education further to some of the courses and materials we offer here, more information is here.
ImagingKT is made possible through the invaluable participation and collaboration of our continuously growing community of contributors from across Canada.
John Valliant, PhD
Associate Professor, Department of Chemistry and Chemical Biology, McMaster University
Scientific Director and CEO, Centre for Probe Development and Commercialization
Research Focus
Developing new radiolabeling methods and compound discovery strategies to create clinically relevant molecular imaging probes and therapeutic radiopharmaceuticals.
Jean-Claude Tardif MD, FRCPC
Professor, Universite de Montreal
Cardiologist and Director of Research Centre, Montreal Heart Institute
Scientific Director, Montreal Heart Institute Coordinating Centre
Director, Cardiovascular Health Network of Fonds de Recherche en Santé du Québec
Canadian Institutes of Health Research and Pfizer Chair in Atherosclerosis
Research Focus
My research covers the molecular and genomic aspects of atherosclerosis and related diseases and also involves animal models, mechanistic and observational clinical studies as well as large international randomized clinical trials. I have been the international principal investigator or part of the study leadership of several large clinical trials in the field of atherosclerosis and other cardiovascular diseases. My team and I have created the Beaulieu-Saucier Pharmacogenomics Center at the Montreal Heart Institute and have created the Center of Excellence in Personalized Medicine, the latter funded by the Network of Centers of Excellence of Canada and which is also supported by multiple pharmaceutical and biotechnological companies. I am one of the founding members of the Critical Markers of Disease organization, which focuses on the development and better use of biomarkers (CMOD).
David Spence MD, FRCPC, FAHA, FCAHS
Professor of Neurology and Clinical Pharmacology, Western University
Director, Stroke Prevention and Atherosclerosis Research Centre, Robarts Research Institute
Research Focus
My research is based on uses of ultrasound in stroke prevention. We use transcranial Doppler for risk stratification in asymptomatic carotid stenosis and for detection of right-to-left shunts in patients with suspected paradoxical embolism, and measurement of carotid plaque burden for risk stratification, management of patients and genetic research. In CAIN I am chair of Project 2, which is validating preoperative imaging of vulnerable plaque by 3D ultrasound, MRI, CT angio, contrast studies of plaque vascularity and PET/CT imaging of plaque inflammation, with 3D histology of carotid endarterectomy specimens.
I have been greatly influenced by Dr. Henry Barnett, with whom I trained in Neurology. He was the first to show that aspirin reduced the risk of stroke, was PI of the North American Carotid Endarterectomy Study, and a giant in stroke prevention. My greatest personal achievement has been the prevention of approximately 7000 strokes among the 30,000 patients referred to me; my greatest academic achievement has been the pioneering of measurement of carotid plaque burden for risk stratification, management of patients and genetic research.
Alan Moody MBBS, FRCP, FRCR
Senior Scientist, Physical Sciences, Schulich Heart Research Program, Sunnybrook Research Institute
Staff Physician, Medical Imaging, Sunnybrook Health Sciences Centre
Chair and Professor, Department of Medical Imaging, University of Toronto
Associate Professor, Institute of Medical Science, School of Graduate Studies, University of Toronto
Associate Professor, Department of Medical Biophysics, University of Toronto
Research Focus
Vascular imaging
Vascular biology
Atheroma
Perfusion
Thrombosis
Disease process
Magnetic resonance imaging (MRI) has rapidly established itself as a major imaging technique for the visualization of vascular diseases. In particular, magnetic resonance direct thrombus imaging (MRDTI) provides a closer, more in-depth look into occluded arteries, providing information never seen before, and has the potential of changing the standard of imaging everywhere. This new MRI technique aims at early diagnosis and intervention to prevent strokes and heart attacks by detecting vulnerable plaques in arteries of patients who are asymptomatic.
Dr. Moody and his team are interested in developing and incorporating such imaging techniques in a comprehensive effort to identify and stabilize vulnerable plaques in one integrated procedure. Applications of MRDTI in the coronary, renal arteries and aorta are also underway.
The following areas are also under investigation using MRDTI: Ischemia; treatment of occlusive vascular disease; atherosclerotic plaque in the coronary and neurovascular circulations; deep venous thromboses; and diagnostic utility in endometriosis.
John Mercer, PhD
Professor and Division Director, Oncologic Imaging, Department of Oncology, University of Alberta
Research Director, Edmonton PET Centre
Research Focus
My research interests are centered on the development and preclinical assessment of PET radiopharmaceuticals.
My present active research areas include the use of PET prosthetic groups for labeling peptides and oligonucleotides and the use of these constructs in molecular imaging and in particular in the development of apoptosis imaging agents.
Ting-Yim Lee, PhD, FCCPM
Scientist, Robarts Research Institute
Medical Physicist, St. Josephs Health Care
Scientist, Lawson Health Research Institute
Professor, Diagnostic Radiology and Nuclear Medicine, Medical Biophysics, Western University
Research Focus
My research interests include:
Stroke: Accute stroke imaging using CT
Heart Attack: Measurement of Myocardial blood flow using CT
Cancer: Hypoxia imaging using CT
Eric Larose DVM, MD, FRCPC, FAHA
Associate Professor, Department of Medicine, Université Laval
Interventional cardiologist, Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ)
Co-Director, Cardiovascular Magnetic Resonance & Computed Tomography, Joint Cardiology and Radiology Advanced Imaging Sector at IUCPQ
Director, Laboratoire d’Imagerie Cardiovasculaire Avancée (LICA), IUCPQ Research Centre
Research Focus
My research program focuses on atherosclerosis and its screening before it progresses to myocardial infarction, stroke or sudden death.
I strive to advance atherosclerosis imaging research; my team and I are interested in the biological determinants of atherosclerosis instability and the heterogeneity of atherosclerotic disease. Over the past 9 years, I have developed novel methodologies to assess characteristics of atherosclerosis vulnerability in patients, and established CT and MRI cardiovascular imaging core laboratories (LICA) which serve both my own research activities and multicenter trials. Member of many national and international expert committees, I also contribute to the development of guidelines in cardiology and imaging.